Quick Takeaways
- Octagon Capital Advisors LP filed SCHEDULE 13G/A for Unicycive Therapeutics, Inc. Common Stock, $0.001 par value (UNCY).
- Disclosed ownership: 4.7%.
- Date of event: 31 Dec 2025.
Octagon Capital Advisors LP - 31 Dec 2025 SCHEDULE 13G/A Report for Unicycive Therapeutics, Inc. Common Stock, $0.001 par value (UNCY)
- Filing Manager
- Octagon Capital Advisors LP
- Reporting Manager
- Octagon Capital Advisors LP
- Symbol
- UNCY
- Shares outstanding
- 21,276,596 shares
- Disclosed Ownership
- 1,000,000 shares
- Ownership
- 4.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 10 Feb 2026, 13:15:05 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Octagon Capital Advisors LP disclosed 4.7% ownership in Unicycive Therapeutics, Inc. Common Stock, $0.001 par value (UNCY) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 10 Feb 2026, 13:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Octagon Capital Advisors LP | 4.7% | 1,000,000 | 0 | 1,000,000 | /s/ Ting Jia | Managing Member | |
| Octagon Investments Master Fund LP | 3% | 650,000 | 0 | 650,000 | /s/ Ting Jia | Managing Member, Octagon Investments GP, LLC, its general partner | |
| Octagon Biotech Opportunities Fund I LP | 1.7% | 350,000 | 0 | 350,000 | /s/ Ting Jia | Managing Member, Octagon Investments GP, LLC, its general partner | |
| Ting Jia | 4.7% | 1,000,000 | 0 | 1,000,000 | /s/ Ting Jia | Ting Jia |